Login
PURE Biosciences Inc logo

PURE Biosciences Inc

purebio.com

PURE Biosciences (OTC: PURE) is a specialty chemical company that develops and sells antimicrobial cleaning, sanitizing, and disinfecting products built on its proprietary Silver Dihydrogen Citrate (SDC) technology. Revenue comes from direct product sales to food service operators, food processors, healthcare facilities, and commercial facility operators. Core commercial products include PURE Hard Surface, a food contact surface sanitizer and disinfectant, PURE Control, a direct food contact processing aid seeking FDA and USDA regulatory approval, and a line of SDC-enhanced cleaners including PURE Multi-Purpose and Floor Cleaner and PURE Hi-Foam Cleaner Concentrate. As of July 31, 2025, the company held $409,000 in cash, carried $6,174,000 in total liabilities including $1,800,000 in outstanding convertible notes, and had auditors express substantial doubt about its ability to continue as a going concern. The company has a history of losses and has funded operations partly through convertible note issuances to board-affiliated investors.

Products & Services

PURE Hard Surface (food contact surface sanitizer and disinfectant), PURE Control (direct food contact processing aid, pending FDA and USDA approval), PURE Multi-Purpose and Floor Cleaner, PURE Multi-Purpose Hi-Foam Cleaner Concentrate. All products are formulated with SDC, the company's non-toxic antimicrobial compound, and are positioned as free from bleach, ammonia, phosphates, EDTA, and VOCs.

Revenue Model

Transactional product sales of antimicrobial cleaning and sanitizing products to institutional end markets. The company has also received non-recurring government credits, including $175,000 from the U.S. Employee Retention Tax Credit Program recognized in the fiscal year ended July 31, 2025.

Customers & Markets

Food service and hospitality operators, food processors, transportation companies, hospitals, assisted living facilities, clinics, childcare centers, schools, gyms, and commercial office buildings. The company targets institutional buyers requiring food safety and infection control compliance.

Financial Snapshot

Revenue
TTM
$2.420M
Gross Margin
TTM
57.95%
Net Income
TTM
-$2.205M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
42.39%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
-$5.839M
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $8.3211 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support